Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2012 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (182)	2/17/2012 8:48:32 PM
From: FiloF	Respond to of 513

9 zinc fingers. Heh heh. Nice work. Have a great weekend, all.

To: BulbaMan who wrote (182)	2/20/2012 2:13:29 PM
From: The Ox	Respond to of 513

Very much appreciated! Thanks again.

To: BulbaMan who wrote (182)	2/24/2012 5:32:29 PM
From: BulbaMan	Read Replies (1) \| Respond to of 513

2/24/12 Contest Update An FDA panel’s 20-2 thumbs up for Vivus’s weight-loss drug provided a weight gain for four Contest portfolios. And the VVUS vote, along with good news for a few other biotechs, helped maintain the Contest median’s outperformance. At Friday’s close, the Contest median was up 22.75% YTD (vs. up 21.77% YTD a week ago). In comparison, the NBI was up 14.39% YTD (vs. up 13.91% YTD a week ago), while the Nasdaq Composite Index was up 13.77% YTD (vs. up 13.31% YTD a week ago). GENE’s portfolio, up 44.10% YTD, got the Gold with a superb DSCO toss. With 15% allocated to VVUS, BIOJIM’s portfolio, up 40.28% YTD, took the Silver and DON’s portfolio, up 39.09% YTD, took the Bronze. At Friday's close, all 38 Contest portfolios remained in the black, with even the poorest performing portfolio up 4.58% YTD. And 28 of the 38 portfolios were doing better than the NBI. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week. And I’m again posting the YTD (using 12/30/11 closing prices) Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost. (Foreign stock prices are not converted to US$ in the weekly and YTD Top 5 & Bottom 5 tables.) Portfolio adjustments: None Have a terrific weekend biotechies! (All corrections, especially adjustments for splits, greatly appreciated.) 2/24/12 Rank Name Profit/Loss 1 GENE 44,097 2 BIOJIM 40,277 3 DONS 39,091 4 ROBERT 38,869 5 PGO 38,716 6 RKRW 35,511 7 BIOFISH 34,682 8 SCARAM 33,608 9 BIOMAV 32,532 10 ARTHUR 31,839 Week's Top 5 Gainers Symbol 2/17/12 2/24/12 Wk. % chg. VVUS 11.99 22.13 84.57% THLD 3.53 6.08 72.24% CORT 3.03 4.35 43.50% DSCO 2.63 3.40 29.28% CHTP 3.35 3.88 15.82% Week's Top 5 Losers Symbol 2/17/12 2/24/12 Wk. % chg. DARA 2.60 1.82 -30.00% CLDX 4.87 3.85 -20.94% PBTH 6.20 5.44 -12.26% YMI 2.26 2.00 -11.50% BLRX 3.64 3.25 -10.71% YTD Top 5 Gainers Symbol 12/30/11 2/24/12 YTD %chg. THLD 1.22 6.08 398.36% BDSI 0.81 2.25 179.47% VVUS 9.75 22.13 126.97% DSCO 1.68 3.40 102.38% DNDN 7.60 14.86 95.53% YTD Top 5 Losers Symbol 12/30/11 2/24/12 YTD %chg. AMRS 11.54 6.00 -48.01% DRRX 1.18 0.75 -36.44% NGSX 0.82 0.60 -26.71% TSRX 7.15 5.33 -25.45% CHTP 5.13 3.88 -24.37%